# Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

> **NCT04979793** · PHASE1 · SUSPENDED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 338 (estimated)

## Conditions studied

- Pregnancy Induced Hypertension
- Preeclampsia and Eclampsia
- Gestational Hypertension

## Interventions

- **DRUG:** L-citrulline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04979793
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-07-28
- **Primary completion:** 2027-07-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 338 (ESTIMATED)
- **Why stopped:** At the request of the PI
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979793, "Role of L-citrulline in Prevention of Pregnancy Associated Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04979793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*